Temat: "NECK" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Elective neck dissection versus elective neck irradiation in cT3/4N0 maxillary sinus squamous cell carcinoma: a propensity score matching analysis.
Autorzy:: Chen M; Department of Stomatology, Shaoxing People's Hospital, Zhejiang, PR China.
Gu H; Department of Stomatology, Shaoxing People's Hospital, Zhejiang, PR China.
Xuan G; Department of Stomatology, Shaoxing People's Hospital, Zhejiang, PR China.
Ma L; Department of Stomatology, Shaoxing People's Hospital, Zhejiang, PR China.
Tu S; Department of Stomatology, Shaoxing People's Hospital, Zhejiang, PR China.
Li M; Department of Stomatology, Shaoxing People's Hospital, Zhejiang, PR China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2024 Apr 15; Vol. 22 (1), pp. 95. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/pathology
Humans ; Neck Dissection ; Maxillary Sinus/pathology ; Retrospective Studies ; Propensity Score ; Quality of Life ; Squamous Cell Carcinoma of Head and Neck/pathology ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
Autorzy:: Yang F; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Yuan C; Department of Biostatistics and Bioinformatics, Rolling School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Chen F; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Qin ZS; Department of Biostatistics and Bioinformatics, Rolling School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Schmitt NC; Department of Otolaryngology, Emory University, Atlanta, GA, 30322, USA.
Lesinski GB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA. .; Department of Oral Biology and Diagnostic Sciences, Georgia Cancer Center, Augusta University, Augusta, GA, 30912, USA. .; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30322, USA. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 12; Vol. 43 (1), pp. 76. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Papillomavirus Infections*/complications
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/metabolism
Animals ; Mice ; Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/metabolism ; Interleukin-6/metabolism ; Neoplasm Recurrence, Local/metabolism ; Killer Cells, Natural ; Receptors, CCR2/genetics ; Receptors, CCR2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
Autorzy:: Ding Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Lin F; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Huang Z; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Li Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Cai S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Chen X; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Liu H; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China. .
Qiu S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 23; Vol. 14 (1), pp. 4426. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Cell Adhesion Molecules*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Humans ; Biomarkers ; Down-Regulation ; Prognosis ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.
Autorzy:: Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Sánchez-Canteli M; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain. .; Department of Otolaryngology, Hospital Universitario de Cabueñes and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain. .
Otero-Rosales M; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Martínez-Camblor P; Department of Anesthesiology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.; Faculty of Health Sciences, Universidad Autonoma de Chile, 7500912, Providencia, Chile.
Hermida-Prado F; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
García-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 04; Vol. 22 (1), pp. 135. Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Immunotherapy*/methods
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prognosis ; Survival Analysis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Mutation/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Early recurrence, time-to-recurrence, and recurrence patterns: Assessing their impact on survival outcomes in head and neck squamous cell carcinoma (R/M-HNSCC) patients treated with first line platinum-based chemotherapy.
Autorzy:: Pitakpaiboonkul P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Jiarpinitnun C; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pattaranutaporn P; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Ngamphaiboon N; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7047.
Typ publikacji:: Journal Article
MeSH Terms:: Platinum*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/chemically induced ; Cetuximab ; Retrospective Studies ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC.
Autorzy:: Geyer F; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany. .
Geyer M; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany.
Reuning U; Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, 81675, Munich, Germany.
Klapproth S; Institute of Experimental Hematology, School of Medicine, Technische Universität München, 81675, Munich, Germany.
Wolff KD; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany.
Nieberler M; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8286. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/radiotherapy
Head and Neck Neoplasms*/complications
Papillomavirus Infections*
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Squamous Cell Carcinoma of Head and Neck/complications ; Prognosis ; Cell Line, Tumor ; Mi-2 Nucleosome Remodeling and Deacetylase Complex

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Effects of scapular treatment on chronic neck pain: a systematic review and meta-analysis of randomized controlled trials.
Autorzy:: Chen Y; Department of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China, #37, Guo Xue Lane.; College of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.; Sichuan Provincial Key Laboratory of Rehabilitation Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.
Yang C; Department of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China, #37, Guo Xue Lane.; College of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.; Sichuan Provincial Key Laboratory of Rehabilitation Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.
Nie K; Department of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China, #37, Guo Xue Lane.; College of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.; Sichuan Provincial Key Laboratory of Rehabilitation Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.
Huang J; Department of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China, #37, Guo Xue Lane.; College of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.; Sichuan Provincial Key Laboratory of Rehabilitation Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.
Qu Y; Department of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China, #37, Guo Xue Lane.; College of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.; Sichuan Provincial Key Laboratory of Rehabilitation Medicine, Sichuan University, Chengdu, 610041, Sichuan, China.
Wang T; Department of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China, #37, Guo Xue Lane. .; College of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China. .; Sichuan Provincial Key Laboratory of Rehabilitation Medicine, Sichuan University, Chengdu, 610041, Sichuan, China. .; Pokaż więcej
Źródło:: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Apr 01; Vol. 25 (1), pp. 252. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Neck Pain*/diagnosis
Neck Pain*/drug therapy
Chronic Pain*/diagnosis
Chronic Pain*/drug therapy
Male ; Humans ; Female ; Quality of Life ; Randomized Controlled Trials as Topic ; Neck ; Scapula

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
Autorzy:: Guan Z; Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Liu J; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, NO.1 Jianshedong Road, Zhengzhou, 450052, Henan, China.
Zheng L; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, NO.1 Jianshedong Road, Zhengzhou, 450052, Henan, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 15; Vol. 14 (1), pp. 6304. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/radiotherapy
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/radiotherapy
Mouth Neoplasms*/genetics
Mouth Neoplasms*/radiotherapy
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Glucose

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
Autorzy:: Hoesseini A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands. .
Sewnaik A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
van den Besselaar BN; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Zhang J; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
van Leeuwen N; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
Hardillo JA; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Baatenburg de Jong RJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Offerman MPJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.; Pokaż więcej
Źródło:: BMC palliative care [BMC Palliat Care] 2024 Feb 24; Vol. 23 (1), pp. 54. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/therapy ; Prognosis ; Proportional Hazards Models

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.
Autorzy:: Broghammer F; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Korovina I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Gouda M; Department of Otorhinolaryngology, Head and Neck Surgery, Ludwigs-Maximilians-University University Hospital, 81377, Munich, Germany.
Celotti M; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
van Es J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
Lange I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Brunner C; Department of Otorhinolaryngology, Ulm University Medical Center, 89075, Ulm, Germany.
Mircetic J; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Mildred Scheel Early Career Center (MSNZ) P2, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Coppes RP; Department of Biomedical Sciences of Cells and Systems, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.
Gires O; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Dahl A; DRESDEN-Concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.
Seifert M; Institute for Medical Informatics and Biometry (IMB), Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany.
Cordes N; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany. .; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany. .; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. .; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany. .; Department of Radiotherapy and Radiation Oncology, University Hospital Carl Gustav Carus, 01307, Dresden, Germany. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Feb 21; Vol. 23 (1), pp. 39. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Antineoplastic Agents*/therapeutic use
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Integrin beta1/genetics ; Cell Line, Tumor ; Receptor Protein-Tyrosine Kinases/genetics ; ErbB Receptors/metabolism ; Phenotype ; Epithelial-Mesenchymal Transition/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC.
Autorzy:: Rahman MM; Rangamati Medical College, Rangamati, Bangladesh.; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Hossain MM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh. .; EuGEF Research Foundation, Chattogram, Bangladesh. .
Islam S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.; Present Address: Stem Cell Genetics, Institute of Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Ahmed R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Majumder M; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Dey S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Kawser M; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Sarkar B; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Himu MER; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Chowdhury AA; Department of Radiotherapy, Chittagong Medical College, Chattogram, Bangladesh.
Ahmed S; Department of Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Biswas S; Department of Otolaryngology and Head Neck Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Anwar MM; Department of Otolaryngology and Head Neck Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Hussain MJ; Department of Otolaryngology and Head Neck Surgery, Rangamati Medical College, Rangamati, Bangladesh.
Kumar Shil R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Baidya S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Parial R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Islam MM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Bharde A; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Jayant S; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Aland G; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Khandare J; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Uddin SB; Department of Botany, University of Chittagong, Chattogram, Bangladesh.
Noman ASM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh. .; EuGEF Research Foundation, Chattogram, Bangladesh. .; Pokaż więcej
Źródło:: BMC molecular and cell biology [BMC Mol Cell Biol] 2024 Feb 10; Vol. 25 (1), pp. 4. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:: Journal Article
MeSH Terms:: NF-E2-Related Factor 2*
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prospective Studies ; Hedgehog Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma.
Autorzy:: Huang Y; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Liu H; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Liu B; Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, China.
Chen X; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Li D; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Xue J; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Li N; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Zhu L; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Yang L; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Xiao J; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China. .; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China. .
Liu C; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China. .; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China. .; Pokaż więcej
Źródło:: BMC medical genomics [BMC Med Genomics] 2024 Feb 08; Vol. 17 (1), pp. 49. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/therapy ; Mutation ; Prognosis ; Biomarkers, Tumor/genetics ; Immunotherapy ; Epithelial-Mesenchymal Transition/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11.
Autorzy:: Idel C; Department of Otorhinolaryngology and Head & Neck Surgery, University of Luebeck, Luebeck, 23538, Germany.
Fleckner J; Department of Otorhinolaryngology and Head & Neck Surgery, University of Luebeck, Luebeck, 23538, Germany.
Plötze-Martin K; Department of Otorhinolaryngology and Head & Neck Surgery, University of Luebeck, Luebeck, 23538, Germany.
Werner L; Department of Otorhinolaryngology and Head & Neck Surgery, University of Luebeck, Luebeck, 23538, Germany.
Rades D; Department of Radiation Oncology, University of Luebeck, Luebeck, 23538, Germany.
Theodoraki MN; Department of Otorhinolaryngology and Head & Neck Surgery, Ulm University Medical Center, Ulm, 89075, Germany.; Department of Otorhinolaryngology, Technical University Munich, Munich, Germany.
Hofmann L; Department of Otorhinolaryngology and Head & Neck Surgery, Ulm University Medical Center, Ulm, 89075, Germany.
Huber D; Department of Otorhinolaryngology and Head & Neck Surgery, Ulm University Medical Center, Ulm, 89075, Germany.
Leichtle A; Department of Otorhinolaryngology and Head & Neck Surgery, University of Luebeck, Luebeck, 23538, Germany.
Hoffmann TK; Department of Otorhinolaryngology and Head & Neck Surgery, Ulm University Medical Center, Ulm, 89075, Germany.
Bruchhage KL; Department of Otorhinolaryngology and Head & Neck Surgery, University of Luebeck, Luebeck, 23538, Germany.
Pries R; Department of Otorhinolaryngology and Head & Neck Surgery, University of Luebeck, Luebeck, 23538, Germany. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 12; Vol. 24 (1), pp. 459. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:: Journal Article
MeSH Terms:: Monocytes*
Head and Neck Neoplasms*/therapy
Humans ; B7-H1 Antigen ; Squamous Cell Carcinoma of Head and Neck/therapy ; Chemokine CXCL11 ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
Autorzy:: Cheng Y; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China.; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China.
Song Z; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China.; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China.
Fang X; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China. .; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China. .
Tang Z; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China. .; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China. .; Pokaż więcej
Źródło:: Clinical epigenetics [Clin Epigenetics] 2024 Apr 10; Vol. 16 (1), pp. 54. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Enhancer of Zeste Homolog 2 Protein*/antagonists & inhibitors
Enhancer of Zeste Homolog 2 Protein*/metabolism
Squamous Cell Carcinoma of Head and Neck*/drug therapy
Humans ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/metabolism ; DNA Methylation ; Epigenesis, Genetic ; Head and Neck Neoplasms/drug therapy ; Mouth Neoplasms/drug therapy ; Polycomb Repressive Complex 2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Autorzy:: Cirillo A; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Marinelli D; Department of Experimental Medicine, Sapienza University, 00161, Rome, Italy. .
Romeo U; Department of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Messineo D; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
De Felice F; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
De Vincentiis M; Department of Sense Organs, Sapienza University, 00161, Rome, Italy.
Valentini V; Department of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Mezi S; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Valentini F; Department of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Vivona L; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Chiavassa A; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
Cerbelli B; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, 04100, Latina, Italy.
Santini D; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, 04100, Latina, Italy.
Bossi P; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25121, Brescia, Italy.
Polimeni A; Department of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
Marchetti P; Istituto Dermopatico dell'Immacolata (IDI-IRCCS), 00167, Rome, Italy.
Botticelli A; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 430. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents, Immunological*/adverse effects
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/chemically induced
Antibodies, Monoclonal, Humanized*
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; B7-H1 Antigen ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Single-cell RNA sequencing explores the evolution of the ecosystem from leukoplakia to head and neck squamous cell carcinoma.
Autorzy:: Wang H; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Guan Z; Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zheng L; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 06; Vol. 14 (1), pp. 8097. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:: Journal Article
MeSH Terms:: Ecosystem*
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Leukoplakia ; Sequence Analysis, RNA ; Prognosis ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: The effects of Phoniatric PREhabilitation in Head and Neck Cancer patients on Aspiration and Preservation of Swallowing (PREHAPS): study protocol of a monocentric prospective randomized interventional outcome-blinded trial.
Autorzy:: Kuenzel J; Department of Otorhinolaryngology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany. .
Duerr S; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Vester S; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Zeman F; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Huppertz G; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Pfleger G; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Woertgen A; Department of Otorhinolaryngology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany.
Salloum H; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Klinkhammer-Schalke M; Institute for Quality Management and Health Services Research, University Hospital Regensburg, Regensburg, Germany.
Pukrop T; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Kummer P; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.; Pokaż więcej
Źródło:: Trials [Trials] 2024 Mar 22; Vol. 25 (1), pp. 211. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Head and Neck Neoplasms*/surgery
Deglutition Disorders*/diagnosis
Deglutition Disorders*/etiology
Deglutition Disorders*/prevention & control
Humans ; Deglutition ; Squamous Cell Carcinoma of Head and Neck ; Preoperative Exercise ; Quality of Life ; Prospective Studies ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Nivolumab plus ipilimumab versus the EXTREME regimen in recurrent/metastatic squamous cell carcinoma of the head and neck: a cost-effectiveness analysis.
Autorzy:: Ye D; Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Liang X; Phase 1 Clinical Trial Laboratory, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Chen X; Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China. .; Phase 1 Clinical Trial Laboratory, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China. .
Li Y; Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 21; Vol. 14 (1), pp. 6807. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/drug therapy
Head and Neck Neoplasms*/drug therapy
Humans ; United States ; Nivolumab/therapeutic use ; Ipilimumab/therapeutic use ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Cost-Effectiveness Analysis ; Cost-Benefit Analysis ; Cetuximab

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma.
Autorzy:: Sarubo M; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Mouri Y; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Moromizato A; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Yamada A; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Jin S; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Shao W; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Hagita H; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Miyoshi K; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Kudo Y; Department of Oral Bioscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 21; Vol. 14 (1), pp. 6767. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/pathology
Humans ; Squamous Cell Carcinoma of Head and Neck/pathology ; Cell Line, Tumor ; Neoplastic Stem Cells/metabolism ; Epithelial-Mesenchymal Transition/genetics ; RNA/metabolism ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Polygenic risk score-based phenome-wide association study of head and neck cancer across two large biobanks.
Autorzy:: Lee YC; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Jung SH; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Shivakumar M; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Cha S; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Park WY; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Won HH; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Samsung Medical Center, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Eun YG; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Biobank PM; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kim D; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .; Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2024 Mar 14; Vol. 22 (1), pp. 120. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Genome-Wide Association Study*/methods
Head and Neck Neoplasms*/genetics
Humans ; Genetic Risk Score ; Squamous Cell Carcinoma of Head and Neck/genetics ; Biological Specimen Banks ; Genetic Predisposition to Disease

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""NECK"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji